NCT00019435View on ClinicalTrials.gov

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1998

Conditions
Bladder CancerBreast CancerColorectal CancerEsophageal CancerGastric CancerLung CancerPancreatic Cancer
Interventions
BIOLOGICAL

LMB-9 immunotoxin

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019435 - LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter